DUTCH Weight Control in Atrial Fibrillation Study
Conditions: Atrial Fibrillation; Obesity; Weight Loss Interventions: Drug: Semaglutide 3.2 MG/ML; Drug: Placebo Sponsors: Rijnstate Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Atrial Fibrillation | Eating Disorders & Weight Management | Hospitals | Netherlands Health | Obesity | Research | Study | Weight Loss